I had the pleasure of working with Atttorney David Carney for my Vaccine Injury Case
Deficiencies or imbalances can exacerbate symptoms such as pain, inflammation, bloating, and fatigue
This body of evidence provides a mechanistic rationale for advancing GLP-1R agonists as candidate pharmacotherapies for AUD, with relevance for individuals characterized by specific genetic profiles, nicotine co-use, or metabolic vulnerability
Effects of fructose restriction on liver steatosis (FRUITLESS)
Why GLP-1 Medications Are Prescribed GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide are approved for: Adults with a body mass index (BMI) of 30 or greater Adults with a BMI of 27 or greater with at least one weight-related condition such as hypertension, type 2 diabetes, or high cholesterol These medications mimic the GLP-1 hormone, which helps regulate appetite, glucose levels, and insulin secretion